McLaren Cancer Institute-Clarkston is a clinical research site located in Clarkston, Michigan, United States 48346.
Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.
McLaren Cancer Institute-Clarkston has participated in 60 clinical trials with 41 currently active.
Therapeutic areas: Plasma Cell Myeloma, Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma.
Sponsors: ECOG-ACRIN Cancer Research Group, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).
Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
McLaren Cancer Institute-Clarkston has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
McLaren Cancer Institute-Clarkston has 60 clinical trials on record, with 41 currently active. Their work covers Plasma Cell Myeloma, Colorectal Adenocarcinoma, Limited Stage Lung Small Cell Carcinoma.
McLaren Cancer Institute-Clarkston has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.